Return to search results
Verapamil hydrochloride
Verapamil Hydrochloride is a prescription injectable medication (2.5 mg/mL) used intravenously to treat conditions like high blood pressure and certain heart rhythm issues by blocking calcium channels, helping relax blood vessels and improve blood flow. Manufactured by Gland Pharma Limited under ANDA214361. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Verapamil Hydrochloride is a prescription injectable medication (2.5 mg/mL) used intravenously to treat conditions like high blood pressure and certain heart rhythm issues by blocking calcium channels, helping relax blood vessels and improve blood flow. Manufactured by Gland Pharma Limited under ANDA214361. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Verapamil hydrochloride",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Verapamil hydrochloride — ANDA 214361 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214361"
}
]
|
| identifier | ANDA214361 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-safety",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Verapamil hydrochloride |
